Lobe Sciences Ltd.
LOBE
CNSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -656.20K | -1.41M | -700.10K | -491.30K | -582.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -365.50K | 303.30K | -30.30K | 117.80K | 223.60K |
| Change in Net Operating Assets | 607.00K | 820.20K | 440.10K | 116.80K | 181.70K |
| Cash from Operations | -414.70K | -290.60K | -290.30K | -256.60K | -176.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 473.90K | -1.23M | -- | -- | -- |
| Cash from Investing | 473.90K | -1.23M | -- | -- | -- |
| Total Debt Issued | -- | -8.34M | 8.33M | 180.20K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50.00K | 96.90K | 248.70K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 8.25M | -248.70K | 248.70K | -- |
| Cash from Financing | 35.80K | 4.10K | 5.92M | 299.70K | -- |
| Foreign Exchange rate Adjustments | 3.50K | -25.10K | 19.30K | -44.00K | 22.40K |
| Miscellaneous Cash Flow Adjustments | 0.00 | -- | -- | -- | -- |
| Net Change in Cash | 98.50K | -1.54M | 5.65M | -900.00 | -154.30K |